Global Medical Radioisotopes Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Medical Radioisotopes market size will reach 806.35 Million USD in 2025 and is projected to reach 1,076.19 Million USD by 2032, with a CAGR of 4.21% (2025-2032). Notably, the China Medical Radioisotopes market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Medical radioisotopes are radioactive substances used in various medical applications, including diagnostic imaging and therapeutic procedures. These isotopes are typically unstable forms of elements that emit radiation as they decay. They are produced in specialized nuclear reactors or particle accelerators and undergo strict quality control measures to ensure their safety and efficacy. In diagnostic imaging, medical radioisotopes are administered to patients either orally or intravenously, allowing healthcare professionals to track their distribution in the body using specialized imaging techniques such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). Therapeutically, radioisotopes can be used to specifically target and destroy cancer cells in a procedure called radiotherapy. Common medical radioisotopes include technetium-99m, iodine-131, and gallium-67, among others. These radioisotopes play a vital role in medical diagnosis, treatment planning, and monitoring disease progression, offering non-invasive and highly precise imaging and therapeutic options to improve patient care.
The major global suppliers of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Polatom, Eckert & Ziegler Strahlen, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Medical Radioisotopes. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Medical Radioisotopes market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Medical Radioisotopes market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Medical Radioisotopes industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Medical Radioisotopes Include:
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Polatom
Eckert & Ziegler Strahlen
Medical Radioisotopes Product Segment Include:
Tc-99m
Cobalt-60
Iodine Radioisotopes
Medical Radioisotopes Product Application Include:
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Medical Radioisotopes Industry PESTEL Analysis
Chapter 3: Global Medical Radioisotopes Industry Porter's Five Forces Analysis
Chapter 4: Global Medical Radioisotopes Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Medical Radioisotopes Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Medical Radioisotopes Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Medical Radioisotopes Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Medical Radioisotopes market size will reach 806.35 Million USD in 2025 and is projected to reach 1,076.19 Million USD by 2032, with a CAGR of 4.21% (2025-2032). Notably, the China Medical Radioisotopes market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Medical radioisotopes are radioactive substances used in various medical applications, including diagnostic imaging and therapeutic procedures. These isotopes are typically unstable forms of elements that emit radiation as they decay. They are produced in specialized nuclear reactors or particle accelerators and undergo strict quality control measures to ensure their safety and efficacy. In diagnostic imaging, medical radioisotopes are administered to patients either orally or intravenously, allowing healthcare professionals to track their distribution in the body using specialized imaging techniques such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). Therapeutically, radioisotopes can be used to specifically target and destroy cancer cells in a procedure called radiotherapy. Common medical radioisotopes include technetium-99m, iodine-131, and gallium-67, among others. These radioisotopes play a vital role in medical diagnosis, treatment planning, and monitoring disease progression, offering non-invasive and highly precise imaging and therapeutic options to improve patient care.
The major global suppliers of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Polatom, Eckert & Ziegler Strahlen, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Medical Radioisotopes. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Medical Radioisotopes market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Medical Radioisotopes market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Medical Radioisotopes industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Medical Radioisotopes Include:
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Polatom
Eckert & Ziegler Strahlen
Medical Radioisotopes Product Segment Include:
Tc-99m
Cobalt-60
Iodine Radioisotopes
Medical Radioisotopes Product Application Include:
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Medical Radioisotopes Industry PESTEL Analysis
Chapter 3: Global Medical Radioisotopes Industry Porter's Five Forces Analysis
Chapter 4: Global Medical Radioisotopes Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Medical Radioisotopes Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Medical Radioisotopes Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Medical Radioisotopes Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Medical Radioisotopes Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Medical Radioisotopes Product by Type
- 1.2.1 Tc-99m
- 1.2.2 Cobalt-60
- 1.2.3 Iodine Radioisotopes
- 1.3 Medical Radioisotopes Product by Application
- 1.3.1 Nuclear Therapy
- 1.3.2 Equipment Radioactive Source
- 1.3.3 Diagnosis
- 1.3.4 Others
- 1.4 Global Medical Radioisotopes Market Size Analysis (2020-2032)
- 1.5 Medical Radioisotopes Market Development Status and Trends
- 1.5.1 Medical Radioisotopes Industry Development Status Analysis
- 1.5.2 Medical Radioisotopes Industry Development Trends Analysis
- 2 Medical Radioisotopes Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Medical Radioisotopes Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Medical Radioisotopes Market Analysis by Country
- 4.1 Global Medical Radioisotopes Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Medical Radioisotopes Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Medical Radioisotopes Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.5 China Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.6 France Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.14 India Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Medical Radioisotopes Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Medical Radioisotopes Market Revenue by Key Suppliers (2021-2025)
- 5.2 Medical Radioisotopes Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Medical Radioisotopes Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Medical Radioisotopes Market Analysis by Type
- 6.1 Global Medical Radioisotopes Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Medical Radioisotopes Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 NRG
- 7.1.1 NRG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 NRG Medical Radioisotopes Product Portfolio
- 7.1.3 NRG Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 IRE
- 7.2.1 IRE Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 IRE Medical Radioisotopes Product Portfolio
- 7.2.3 IRE Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 ANSTO
- 7.3.1 ANSTO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 ANSTO Medical Radioisotopes Product Portfolio
- 7.3.3 ANSTO Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 NTP Radioisotopes
- 7.4.1 NTP Radioisotopes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 NTP Radioisotopes Medical Radioisotopes Product Portfolio
- 7.4.3 NTP Radioisotopes Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 China National Nuclear Corporation
- 7.5.1 China National Nuclear Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 China National Nuclear Corporation Medical Radioisotopes Product Portfolio
- 7.5.3 China National Nuclear Corporation Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Rosatom
- 7.6.1 Rosatom Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Rosatom Medical Radioisotopes Product Portfolio
- 7.6.3 Rosatom Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Nordion
- 7.7.1 Nordion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Nordion Medical Radioisotopes Product Portfolio
- 7.7.3 Nordion Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Polatom
- 7.8.1 Polatom Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Polatom Medical Radioisotopes Product Portfolio
- 7.8.3 Polatom Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Eckert & Ziegler Strahlen
- 7.9.1 Eckert & Ziegler Strahlen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Eckert & Ziegler Strahlen Medical Radioisotopes Product Portfolio
- 7.9.3 Eckert & Ziegler Strahlen Medical Radioisotopes Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Medical Radioisotopes Industry Chain Analysis
- 8.2 Medical Radioisotopes Product Downstream Application Analysis
- 8.2.1 Global Medical Radioisotopes Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Medical Radioisotopes Revenue and Forecast by Application (2020-2032)
- 8.3 Medical Radioisotopes Typical Downstream Customers
- 8.4 Medical Radioisotopes Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
